Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/Sales ratio high or low?
The EV/Sales ratio of 63.12x is 295% above its estimated 5-year average of 15.99x, near the high end of its estimated 5-year range (2.87x–83.70x).
As of 2026-10-06T18:04:19.805Z. 196.26% above its estimated 12-month average of 21.31x.
Calculation as of: 2026-10-06T18:04:19.805Z.
Quote observation: 2026-10-06T18:00:24.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 3dc852dbbee421fd1d0f2104bcbe090e37fdd8a7ae3294fdff0c13dff3b4c360
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
63.12x
EV/SALES RATIO AVG TTM
21.31x
EV/SALES RATIO AVG 3Y
16.01x
EV/SALES RATIO AVG 5Y
15.99x
EV/SALES RATIO AVG 10Y
N/A
EV/SALES RATIO AVG 15Y
N/A
EV/SALES RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+196.26%
CURRENT VS 3Y AVG
+294.33%
CURRENT VS 5Y AVG
+294.80%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.34x
median of 544 covered companies
CURRENT VS SECTOR MEDIAN
+1354.38%
vs the sector median at left
Nurix Therapeutics, Inc.
Market Cap
$2.33B
EV/Sales Ratio
63.12x
TTM Avg
21.31x
3Y Avg
16.01x
5Y Avg
15.99x
Market Cap
$2.33B
EV/Sales Ratio
4.83x
TTM Avg
36.32x
3Y Avg
51.31x
5Y Avg
39.39x
Market Cap
$2.33B
EV/Sales Ratio
3.89x
TTM Avg
3.28x
3Y Avg
4.01x
5Y Avg
3.61x
Market Cap
$2.36B
EV/Sales Ratio
4.74x
TTM Avg
6.25x
3Y Avg
8.23x
5Y Avg
6.93x
Market Cap
$2.29B
EV/Sales Ratio
11.50x
TTM Avg
3.07x
3Y Avg
2.80x
5Y Avg
3.21x
Market Cap
$2.28B
EV/Sales Ratio
1.96x
TTM Avg
1.80x
3Y Avg
2.39x
5Y Avg
4.32x
Market Cap
$2.38B
EV/Sales Ratio
34.60x
TTM Avg
23.51x
3Y Avg
28.15x
5Y Avg
52.69x
Market Cap
$2.40B
EV/Sales Ratio
0.89x
TTM Avg
0.75x
3Y Avg
0.67x
5Y Avg
0.62x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nurix Therapeutics, Inc. (NRIX) | $2.33B | 63.12x | 21.31x | 16.01x | 15.99x |
| Liquidia Corporation (LQDA)vs › | $2.33B | 4.83x | 36.32x | 51.31x | 39.39x |
| UFP Technologies, Inc. (UFPT)vs › | $2.33B | 3.89x | 3.28x | 4.01x | 3.61x |
| ADMA Biologics, Inc. (ADMA)vs › | $2.36B | 4.74x | 6.25x | 8.23x | 6.93x |
| Maravai LifeSciences Holdings, Inc. (MRVI)vs › | $2.29B | 11.50x | 3.07x | 2.80x | 3.21x |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.37B | N/A | N/A | N/A | N/A |
| Harmony Biosciences Holdings, Inc. (HRMY)vs › | $2.28B | 1.96x | 1.80x | 2.39x | 4.32x |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.38B | 34.60x | 23.51x | 28.15x | 52.69x |
| Clover Health Investments, Corp. (CLOV)vs › | $2.40B | 0.89x | 0.75x | 0.67x | 0.62x |
| Disc Medicine, Inc. (IRON)vs › | $2.42B | N/A | N/A | N/A | N/A |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/SALES RATIO |
|---|---|
| 2026-10-05 | 68.87x |
| 2026-10-02 | 69.20x |
| 2026-10-01 | 70.26x |
| 2026-09-30 | 71.38x |
| 2026-09-29 | 71.29x |
| 2026-09-28 | 71.26x |
| 2026-09-25 | 69.26x |
| 2026-09-24 | 71.20x |
| 2026-09-23 | 71.89x |
| 2026-09-22 | 77.30x |
| 2026-09-21 | 76.51x |
| 2026-09-18 | 76.60x |
| 2026-09-17 | 76.79x |
| 2026-09-16 | 75.73x |
| 2026-09-15 | 74.76x |
| 2026-09-14 | 76.85x |
| 2026-09-11 | 75.58x |
| 2026-09-10 | 77.72x |
| 2026-09-09 | 79.08x |
| 2026-09-08 | 78.69x |
| 2026-09-04 | 78.72x |
| 2026-09-03 | 76.24x |
| 2026-09-02 | 77.75x |
| 2026-09-01 | 78.42x |
| 2026-08-31 | 77.63x |
| 2026-08-28 | 78.93x |
| 2026-08-27 | 80.96x |
| 2026-08-26 | 80.44x |
| 2026-08-25 | 81.17x |
| 2026-08-24 | 79.11x |
| 2026-08-21 | 80.47x |
| 2026-08-20 | 81.47x |
| 2026-08-19 | 83.70x |
| 2026-08-18 | 81.11x |
| 2026-08-17 | 81.83x |
| 2026-08-14 | 81.47x |
| 2026-08-13 | 81.89x |
| 2026-08-12 | 80.20x |
| 2026-08-11 | 78.18x |
| 2026-08-10 | 77.93x |
| 2026-08-07 | 76.88x |
| 2026-08-06 | 75.94x |
| 2026-08-05 | 75.64x |
| 2026-08-04 | 74.34x |
| 2026-08-03 | 69.90x |
| 2026-07-31 | 69.87x |
| 2026-07-30 | 70.98x |
| 2026-07-29 | 71.05x |
| 2026-07-28 | 72.71x |
| 2026-07-27 | 70.53x |
| 2026-07-24 | 70.38x |
| 2026-07-23 | 71.47x |
| 2026-07-22 | 71.05x |
| 2026-07-21 | 70.68x |
| 2026-07-20 | 68.36x |
| 2026-07-17 | 69.60x |
| 2026-07-16 | 69.44x |
| 2026-07-15 | 71.80x |
| 2026-07-14 | 69.17x |
| 2026-07-13 | 68.36x |
| 2026-07-10 | 69.41x |
| 2026-07-09 | 37.69x |
| 2026-07-08 | 37.10x |
| 2026-07-07 | 37.24x |
| 2026-07-06 | 36.69x |
| 2026-07-02 | 36.58x |
| 2026-07-01 | 36.49x |
| 2026-06-30 | 37.03x |
| 2026-06-29 | 36.40x |
| 2026-06-26 | 34.94x |
| 2026-06-25 | 34.27x |
| 2026-06-24 | 29.42x |
| 2026-06-23 | 28.75x |
| 2026-06-22 | 28.42x |
| 2026-06-18 | 26.74x |
| 2026-06-17 | 26.08x |
| 2026-06-16 | 26.00x |
| 2026-06-15 | 25.96x |
| 2026-06-12 | 25.82x |
| 2026-06-11 | 25.86x |
| 2026-06-10 | 23.29x |
| 2026-06-09 | 23.81x |
| 2026-06-08 | 23.81x |
| 2026-06-05 | 22.28x |
| 2026-06-04 | 23.26x |
| 2026-06-03 | 23.56x |
| 2026-06-02 | 24.93x |
| 2026-06-01 | 26.49x |
| 2026-05-29 | 27.06x |
| 2026-05-28 | 26.92x |
| 2026-05-27 | 26.62x |
| 2026-05-26 | 26.48x |
| 2026-05-22 | 26.66x |
| 2026-05-21 | 26.71x |
| 2026-05-20 | 25.01x |
| 2026-05-19 | 23.20x |
| 2026-05-18 | 23.61x |
| 2026-05-15 | 24.15x |
| 2026-05-14 | 24.36x |
| 2026-05-13 | 24.64x |
| 2026-05-12 | 24.30x |
| 2026-05-11 | 24.79x |
| 2026-05-08 | 25.16x |
| 2026-05-07 | 24.79x |
| 2026-05-06 | 25.71x |
| 2026-05-05 | 25.28x |
| 2026-05-04 | 25.79x |
| 2026-05-01 | 25.60x |
| 2026-04-30 | 25.43x |
| 2026-04-29 | 25.30x |
| 2026-04-28 | 26.02x |
| 2026-04-27 | 25.11x |
| 2026-04-24 | 25.40x |
| 2026-04-23 | 25.24x |
| 2026-04-22 | 25.33x |
| 2026-04-21 | 25.04x |
| 2026-04-20 | 25.96x |
| 2026-04-17 | 26.68x |
| 2026-04-16 | 25.42x |
| 2026-04-15 | 25.85x |
| 2026-04-14 | 24.82x |
| 2026-04-13 | 24.22x |
| 2026-04-10 | 24.41x |
| 2026-04-09 | 24.73x |
| 2026-04-08 | 15.39x |
| 2026-04-07 | 16.24x |
| 2026-04-06 | 15.60x |
| 2026-04-02 | 15.28x |
| 2026-04-01 | 15.25x |
| 2026-03-31 | 15.27x |
| 2026-03-30 | 14.33x |
| 2026-03-27 | 14.44x |
| 2026-03-26 | 15.31x |
| 2026-03-25 | 15.21x |
| 2026-03-24 | 14.07x |
| 2026-03-23 | 14.36x |
| 2026-03-20 | 14.06x |
| 2026-03-19 | 14.62x |
| 2026-03-18 | 14.76x |
| 2026-03-17 | 15.25x |
| 2026-03-16 | 15.14x |
| 2026-03-13 | 14.75x |
| 2026-03-12 | 15.40x |
| 2026-03-11 | 15.78x |
| 2026-03-10 | 15.73x |
| 2026-03-09 | 15.27x |
| 2026-03-06 | 14.82x |
| 2026-03-05 | 14.96x |
| 2026-03-04 | 16.13x |
| 2026-03-03 | 15.62x |
| 2026-03-02 | 15.62x |
| 2026-02-27 | 15.81x |
| 2026-02-26 | 15.96x |
| 2026-02-25 | 15.60x |
| 2026-02-24 | 15.86x |
| 2026-02-23 | 15.14x |
| 2026-02-20 | 15.59x |
| 2026-02-19 | 15.60x |
| 2026-02-18 | 15.25x |
| 2026-02-17 | 15.43x |
| 2026-02-13 | 15.39x |
| 2026-02-12 | 15.53x |
| 2026-02-11 | 15.96x |
| 2026-02-10 | 16.35x |
| 2026-02-09 | 16.64x |
| 2026-02-06 | 16.80x |
| 2026-02-05 | 15.78x |
| 2026-02-04 | 16.46x |
| 2026-02-03 | 16.73x |
| 2026-02-02 | 17.07x |
| 2026-01-30 | 16.43x |
| 2026-01-29 | 17.64x |
| 2026-01-28 | 17.71x |
| 2026-01-27 | 19.26x |
| 2026-01-26 | 18.59x |
| 2026-01-23 | 18.40x |
| 2026-01-22 | 19.24x |
| 2026-01-21 | 18.87x |
| 2026-01-20 | 18.08x |
| 2026-01-16 | 19.06x |
| 2026-01-15 | 18.70x |
| 2026-01-14 | 18.89x |
| 2026-01-13 | 18.77x |
| 2026-01-12 | 18.22x |
| 2026-01-09 | 19.15x |
| 2026-01-08 | 18.47x |
| 2026-01-07 | 18.33x |
| 2026-01-06 | 17.27x |
| 2026-01-05 | 17.33x |
| 2026-01-02 | 17.90x |
| 2025-12-31 | 18.81x |
| 2025-12-30 | 18.87x |
| 2025-12-29 | 19.21x |
| 2025-12-26 | 19.15x |
| 2025-12-24 | 19.21x |
| 2025-12-23 | 19.14x |
| 2025-12-22 | 19.19x |
| 2025-12-19 | 18.36x |
| 2025-12-18 | 17.85x |
| 2025-12-17 | 18.05x |
| 2025-12-16 | 18.68x |
| 2025-12-15 | 18.85x |
| 2025-12-12 | 18.92x |
| 2025-12-11 | 18.92x |
| 2025-12-10 | 19.46x |
| 2025-12-09 | 19.40x |
| 2025-12-08 | 21.33x |
| 2025-12-05 | 17.93x |
| 2025-12-04 | 17.86x |
| 2025-12-03 | 16.66x |
| 2025-12-02 | 16.18x |
| 2025-12-01 | 16.74x |
| 2025-11-28 | 17.52x |
| 2025-11-26 | 17.03x |
| 2025-11-25 | 16.83x |
| 2025-11-24 | 16.98x |
| 2025-11-21 | 16.59x |
| 2025-11-20 | 15.15x |
| 2025-11-19 | 14.15x |
| 2025-11-18 | 12.49x |
| 2025-11-17 | 12.60x |
| 2025-11-14 | 12.61x |
| 2025-11-13 | 12.24x |
| 2025-11-12 | 11.98x |
| 2025-11-11 | 12.67x |
| 2025-11-10 | 12.06x |
| 2025-11-07 | 12.12x |
| 2025-11-06 | 12.33x |
| 2025-11-05 | 12.27x |
| 2025-11-04 | 12.07x |
| 2025-11-03 | 12.43x |
| 2025-10-31 | 12.75x |
| 2025-10-30 | 12.59x |
| 2025-10-29 | 11.50x |
| 2025-10-28 | 11.70x |
| 2025-10-27 | 11.79x |
| 2025-10-24 | 10.89x |
| 2025-10-23 | 10.20x |
| 2025-10-22 | 10.43x |
| 2025-10-21 | 10.22x |
| 2025-10-20 | 10.19x |
| 2025-10-17 | 9.63x |
| 2025-10-16 | 9.82x |
| 2025-10-15 | 10.15x |
| 2025-10-14 | 8.97x |
| 2025-10-13 | 9.51x |
| 2025-10-10 | 9.55x |
| 2025-10-09 | 9.94x |
| 2025-10-08 | 9.11x |
| 2025-10-07 | 8.96x |
| 2025-10-06 | 9.08x |
| 2025-10-03 | 8.54x |
| 2025-10-02 | 8.25x |
| 2025-10-01 | 8.56x |
| 2025-09-30 | 8.40x |
| 2025-09-29 | 8.44x |
| 2025-09-26 | 8.11x |
| 2025-09-25 | 7.54x |
| 2025-09-24 | 7.89x |
| 2025-09-23 | 7.45x |
Showing the most recent 260 of 1,557 data points. The chart above shows the full history.
